社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Onconetix Inc.(ONCO)
1.75
+0.13
+7.69%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
Onconetix Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.onconetix.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Onconetix, Inc.于2018年10月26日在特拉华州注册成立。该公司是一家商业阶段的生物技术公司，专注于为临床医生和患者提供肿瘤学专有疗法、诊断和服务的研究、开发和商业化。该公司目前拥有FDA批准的用于治疗良性前列腺增生（BPH）（一种前列腺疾病）的口服治疗药物EntadFi，以及用于在前列腺癌肿瘤学中筛查和诊断前列腺特异性抗原（PSA）评估不确定的男性的先进专有诊断系统Proclarix。
2025-12-22
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025-12-10
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-10
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-13
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-04
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-10-29
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-10-16
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-10-03
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-09-26
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-09-22
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-09-04
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-08-14
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-13
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-07-16
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-06-16
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
分时
5日
日
周
月
数据加载中...
最高
2.30
今开
1.56
量比
27.17
最低
1.56
昨收
1.63
换手率
66.44%
热议股票
{"pagemeta":{"title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Onconetix Inc.,ONCO,Onconetix Inc.股票,Onconetix Inc.股票老虎,Onconetix Inc.股票老虎国际,Onconetix Inc.行情,Onconetix Inc.股票行情,Onconetix Inc.股价,Onconetix Inc.股市,Onconetix Inc.股票价格,Onconetix Inc.股票交易,Onconetix Inc.股票购买,Onconetix Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"ONCO","data":{"stockData":{"symbol":"ONCO","market":"US","secType":"STK","nameCN":"Onconetix Inc.","latestPrice":1.75,"timestamp":1768942800000,"preClose":1.625,"halted":0,"volume":826009,"delay":0,"changeRate":0.07692307692307693,"floatShares":1243200,"shares":1560668,"eps":-32.579,"marketStatus":"盘前交易","change":0.125,"latestTime":"01-21 05:48:21 EST","open":1.56,"high":2.3,"low":1.56,"amount":1608436.2783438,"amplitude":0.455385,"askPrice":2.11,"askSize":100,"bidPrice":1.65,"bidSize":15,"shortable":3,"etf":0,"ttmEps":-32.579,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769005800000},"marketStatusCode":1,"adr":0,"listingDate":1645160400000,"exchange":"NASDAQ","adjPreClose":1.75,"postHourTrading":{"tag":"盘后","latestPrice":1.78,"preClose":1.75,"latestTime":"19:54 EST","volume":7107,"amount":12580.0668,"timestamp":1768956876882,"change":0.03,"changeRate":0.017143,"amplitude":0.114286},"volumeRatio":27.170276128622756},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20559346","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025124018-ONCO","pdf_url":"","pub_time":1766379600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"ONCO","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025124018/0001213900-25-124018-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025124018/ea0270066-s1a1_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea0270066-s1a1_onconetix.htm","type":"S-1/A","id":"NTFILEJ1Pz3UYrfYkWjgbi","market":"us","size":426165},{"description":"OPINION OF ELLENOFF GROSSMAN & SCHOLE LLP AS TO THE LEGALITY OF THE SECURITIES B","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025124018/ea027006601ex5-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea027006601ex5-1_onconetix.htm","type":"EX-5.1","id":"NTFILEAeD4wi8QTyq5P5zg","market":"us","size":13555},{"description":"CONSENT OF MALONEBAILEY LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025124018/ea027006601ex23-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea027006601ex23-1_onconetix.htm","type":"EX-23.1","id":"NTFILEEJ7LPYWiE2uKAfqH","market":"us","size":1901},{"description":"CONSENT OF EISNERAMPER LLP","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025124018/ea027006601ex23-2_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea027006601ex23-2_onconetix.htm","type":"EX-23.2","id":"NTFILE2aiXxgy9V5chDczr","market":"us","size":2498},{"description":"FILING FEE IXBRL","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025124018/ea027006601ex-fee_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea027006601ex-fee_onconetix.htm","type":"EX-FILING FEES","id":"NTFILE74WKx5VZK95Y94iw","market":"us","size":15129},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025124018/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILErcQdinPzgCRVKzkP","market":"us","size":4427},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025124018/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE2d3g8RmaLG9vrz13","market":"us","size":10413}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2025-12-22 13:00","pubTimestamp":1766379600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20515458","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025120144-ONCO","pdf_url":"","pub_time":1765342800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025120144/0001213900-25-120144-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025120144/ea0269184-8k_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea0269184-8k_onconetix.htm","type":"8-K","id":"NTFILEBNciaDNaxLzdkrcJ","market":"us","size":44120}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-10 13:00","pubTimestamp":1765342800,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目5.07：将事项提交证券持有人表决；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20514421","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025119898-ONCO","pdf_url":"","pub_time":1765342800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025119898/0001213900-25-119898-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FIRST AMENDMENT TO LICENSE AGREEMENT BETWEEN PROTEOMEDIX AG AND LABORATORY CORPO","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025119898/ea026905201ex10-1_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea026905201ex10-1_onconetix.htm","type":"EX-10.1","id":"NTFILEELk84kMrBUYp2bLs","market":"us","size":27531},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025119898/ea0269052-8k_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea0269052-8k_onconetix.htm","type":"8-K","id":"NTFILE45XhgZyszXySFCxZ","market":"us","size":27304}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-10 13:00","pubTimestamp":1765342800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20406770","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025110142-ONCO","pdf_url":"","pub_time":1763010000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ONCO","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025110142/0001213900-25-110142-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025110142/ea0264964-10q_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea0264964-10q_onconetix.htm","type":"10-Q","id":"NTFILEHu86nMtVJSKV76c8","market":"us","size":1643039},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025110142/ea026496401ex31_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea026496401ex31_onconetix.htm","type":"EX-31","id":"NTFILEJ3SwiUETW1g5taf3","market":"us","size":12408},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025110142/ea026496401ex32_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea026496401ex32_onconetix.htm","type":"EX-32","id":"NTFILE4UnrivRDJ5pB48XD","market":"us","size":4813}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-13 13:00","pubTimestamp":1763010000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20368325","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025106177-ONCO","pdf_url":"","pub_time":1762232400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"ONCO","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025106177/0001213900-25-106177-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025106177/ea0263314-s1_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea0263314-s1_onconetix.htm","type":"S-1","id":"NTFILE8zzrCgxDz1VncYBF","market":"us","size":432256},{"description":"CONSENT OF MALONEBAILEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025106177/ea026331401ex23-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea026331401ex23-1_onconetix.htm","type":"EX-23.1","id":"NTFILE478ZFLnyLXwwK26j","market":"us","size":1947},{"description":"CONSENT OF EISNERAMPER LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025106177/ea026331401ex23-2_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea026331401ex23-2_onconetix.htm","type":"EX-23.2","id":"NTFILE53AJuKgqeWjEUgb9","market":"us","size":2347},{"description":"FILING FEE IXBRL","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025106177/ea026331401ex-fee_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea026331401ex-fee_onconetix.htm","type":"EX-FILING FEES","id":"NTFILEWsLAKbGGrapYSRPq","market":"us","size":14977},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025106177/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILECuRbwuB6z8Gpn8tK","market":"us","size":12973}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-11-04 13:00","pubTimestamp":1762232400,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20337163","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025103351-ONCO","pdf_url":"","pub_time":1761710400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025103351/0001213900-25-103351-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025103351/ea0262958-8k_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea0262958-8k_onconetix.htm","type":"8-K","id":"NTFILEH8aRNWuPqzmXhCHV","market":"us","size":24911}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-10-29 12:00","pubTimestamp":1761710400,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20271259","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025099298-ONCO","pdf_url":"","pub_time":1760587200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"ONCO","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025099298/0001213900-25-099298-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025099298/ea0261312-s1_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea0261312-s1_onconetix.htm","type":"S-1","id":"NTFILEAxxzzibxxWynRJe5","market":"us","size":476932},{"description":"OPINION OF ELLENOFF GROSSMAN & SCHOLE LLP AS TO THE LEGALITY OF THE SECURITIES B","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025099298/ea026131201ex5-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea026131201ex5-1_onconetix.htm","type":"EX-5.1","id":"NTFILEBVs8qEKqWEp5NMUL","market":"us","size":8070},{"description":"CONSENT OF MALONEBAILEY LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025099298/ea026131201ex23-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea026131201ex23-1_onconetix.htm","type":"EX-23.1","id":"NTFILE9StphoXmrcykDj7b","market":"us","size":2296},{"description":"CONSENT OF EISNERAMPER LLP","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025099298/ea026131201ex23-2_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea026131201ex23-2_onconetix.htm","type":"EX-23.2","id":"NTFILEHF1mdYFBA1sf4y8C","market":"us","size":2575},{"description":"FILING FEE TABLE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025099298/ea026131201ex-fee_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea026131201ex-fee_onconetix.htm","type":"EX-FILING FEES","id":"NTFILECoHvcDfx4wtZ7TQc","market":"us","size":14191},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025099298/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEAvLc8YPqqaLM9TVM","market":"us","size":13021}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-10-16 12:00","pubTimestamp":1760587200,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20237814","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025095847-ONCO","pdf_url":"","pub_time":1759464000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/0001213900-25-095847-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CERTIFICATE OF DESIGNATIONS AUTHORIZING THE ISSUANCE OF THE SERIES E PREFERRED S","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/ea025986001ex3-1_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea025986001ex3-1_onconetix.htm","type":"EX-3.1","id":"NTFILE2FRSrCBytggUorDm","market":"us","size":318227},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/ea0259860-8k_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea0259860-8k_onconetix.htm","type":"8-K","id":"NTFILEEYbQGVmehx4Q1PjT","market":"us","size":85756},{"description":"FORM OF WARRANT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/ea025986001ex4-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025986001ex4-1_onconetix.htm","type":"EX-4.1","id":"NTFILECGeMzPvcmZP4sicQ","market":"us","size":185174},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT DATED OCTOBER 1, 2025 RELATING TO THE SALE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/ea025986001ex10-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025986001ex10-1_onconetix.htm","type":"EX-10.1","id":"NTFILEDMfRhMmWuhtJtwmP","market":"us","size":298099},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT DATED AS OF OCTOBER 1, 2025 RELATING TO TH","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/ea025986001ex10-2_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025986001ex10-2_onconetix.htm","type":"EX-10.2","id":"NTFILEBgVzYnY1rUatVn2c","market":"us","size":177046}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-10-03 12:00","pubTimestamp":1759464000,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20212118","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025091966-ONCO","pdf_url":"","pub_time":1758859200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/0001213900-25-091966-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 1.02: Termination of a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CERTIFICATE OF DESIGNATIONS AUTHORIZING THE ISSUANCE OF THE SERIES D PREFERRED S","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ea025883001ex3-1_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea025883001ex3-1_onconetix.htm","type":"EX-3.1","id":"NTFILEDVdk76c5XWXRi2fk","market":"us","size":353772},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ea0258830-8k_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea0258830-8k_onconetix.htm","type":"8-K","id":"NTFILE5x52bWVzYMTtZa8i","market":"us","size":98194},{"description":"FORM OF WARRANT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ea025883001ex4-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025883001ex4-1_onconetix.htm","type":"EX-4.1","id":"NTFILEE94NMuWXBCv2Nbpq","market":"us","size":185593},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT DATED SEPTEMBER 22, 2025 RELATING TO THE S","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ea025883001ex10-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025883001ex10-1_onconetix.htm","type":"EX-10.1","id":"NTFILEAwohyBRHf4CK7Ysb","market":"us","size":309077},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT DATED AS OF SEPTEMBER 22, 2025 RELATING TO","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ea025883001ex10-2_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025883001ex10-2_onconetix.htm","type":"EX-10.2","id":"NTFILEB67HzM9U1rVd3EQH","market":"us","size":206088},{"description":"SETTLEMENT AGREEMENT AND RELEASE, DATED SEPTEMBER 22, 2025, BY AND BETWEEN THE C","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ea025883001ex10-3_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025883001ex10-3_onconetix.htm","type":"EX-10.3","id":"NTFILEHJVtgbdp39W14Pz8","market":"us","size":17776},{"description":"FORM OF TERMINATION AGREEMENT EFFECTIVE AS OF SEPTEMBER 24, 2025, BY AND BETWEEN","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ea025883001ex10-4_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025883001ex10-4_onconetix.htm","type":"EX-10.4","id":"NTFILECimjRv4gFYHgZgep","market":"us","size":36330},{"description":"PIPE FINANCING AND SETTLEMENT AGREEMENT PRESS RELEASE DATED SEPTEMBER 26, 2025","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ea025883001ex99-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025883001ex99-1_onconetix.htm","type":"EX-99.1","id":"NTFILE8HR4vbfeB1VU7w42","market":"us","size":9210},{"description":"TERMINATION OF MERGER AGREEMENT PRESS RELEASE DATED SEPTEMBER 26, 2025","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ea025883001ex99-2_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025883001ex99-2_onconetix.htm","type":"EX-99.2","id":"NTFILEECWD5tKPsZicsAEq","market":"us","size":7465},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE6pJpQMu7Y9F7iGgQ","market":"us","size":1838},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025091966/ex99-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_001.jpg","type":"GRAPHIC","id":"NTFILEFzYFaoLpnkLMnQy1","market":"us","size":1838}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-26 12:00","pubTimestamp":1758859200,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 1.02: Termination of a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第1.02项：重大最终协议的终止；第3.02项：未经登记的股本证券销售；第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20193050","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025089845-ONCO","pdf_url":"","pub_time":1758513600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025089845/0001213900-25-089845-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"LICENSE AGREEMENT, DATED SEPTEMBER 17, 2025, BY AND BETWEEN IMMUNOVIA AB AND PRO","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025089845/ea025819601ex10-1_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea025819601ex10-1_onconetix.htm","type":"EX-10.1","id":"NTFILE4Mvk6sSgfmqT4Ehf","market":"us","size":155183},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025089845/ea0258196-8k_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea0258196-8k_onconetix.htm","type":"8-K","id":"NTFILE5psveUPr9dPUgxmD","market":"us","size":27928},{"description":"PRESS RELEASE, DATED SEPTEMBER 22, 2025","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025089845/ea025819601ex99-1_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025819601ex99-1_onconetix.htm","type":"EX-99.1","id":"NTFILECN6cYPpdXYMyyD4L","market":"us","size":10931},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025089845/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEHaf6NEy3ZkLwjHPL","market":"us","size":5327}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-22 12:00","pubTimestamp":1758513600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20130204","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025084500-ONCO","pdf_url":"","pub_time":1756958400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025084500/0001213900-25-084500-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PROMISSORY NOTE, DATED AUGUST 28, 2025, BY AND BETWEEN KEYSTONE CAPITAL PARTNERS","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025084500/ea025595801ex10-1_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea025595801ex10-1_onconetix.htm","type":"EX-10.1","id":"NTFILECvfLTVcR2Ln6sKiG","market":"us","size":28916},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025084500/ea0255958-8k_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea0255958-8k_onconetix.htm","type":"8-K","id":"NTFILE7MNHXobDwxE3Ar79","market":"us","size":38096},{"description":"PROMISSORY NOTE, DATED AUGUST 28, 2025, BY AND BETWEEN KCP FUND I, LLC AND THE C","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025084500/ea025595801ex10-2_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025595801ex10-2_onconetix.htm","type":"EX-10.2","id":"NTFILE7qfXJVZmWidw2NvN","market":"us","size":27922},{"description":"SECOND AMENDED AND RESTATED PROMISSORY NOTE, DATED AUGUST 28, 2025, BY AND BETWE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025084500/ea025595801ex10-3_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025595801ex10-3_onconetix.htm","type":"EX-10.3","id":"NTFILE89HG43Aja1kuLNyv","market":"us","size":27010},{"description":"WAIVER, DATED AUGUST 28, 2025, BY AND BETWEEN VERU, INC. AND THE COMPANY","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025084500/ea025595801ex10-4_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025595801ex10-4_onconetix.htm","type":"EX-10.4","id":"NTFILE9MMpAwrcxhpFbZmQ","market":"us","size":20155}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-04 12:00","pubTimestamp":1756958400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第2.03项：直接财务义务或注册人资产负债表外安排下的义务的产生；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19986752","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025076032-ONCO","pdf_url":"","pub_time":1755144000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ONCO","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025076032/0001213900-25-076032-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025076032/ea0252575-10q_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea0252575-10q_onconetix.htm","type":"10-Q","id":"NTFILEGwkd4AyMukqjU6ja","market":"us","size":1333111},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025076032/ea025257501ex31_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025257501ex31_onconetix.htm","type":"EX-31","id":"NTFILECF4g2EfG5wiqyVcM","market":"us","size":10153},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025076032/ea025257501ex32_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea025257501ex32_onconetix.htm","type":"EX-32","id":"NTFILE3PweMxtnTK99LPJC","market":"us","size":4344}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-08-14 12:00","pubTimestamp":1755144000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19978808","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025074952-ONCO","pdf_url":"","pub_time":1755029168000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/0001213900-25-074952-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PROMISSORY NOTE, DATED AUGUST 6, 2025, BY AND BETWEEN KEYSTONE CAPITAL PARTNERS,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025074952/ea025275901ex10-1_oncone.htm","primary":true,"translateUrl":"","linkName":"ea025275901ex10-1_oncone.htm","type":"EX-10.1","id":"NTFILEE3Q59m1EvjcjHKEf","market":"us","size":31797},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025074952/ea0252759-8k_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea0252759-8k_onconetix.htm","type":"8-K","id":"NTFILEBVsxjNizYneqQim1","market":"us","size":40335},{"description":"AMENDED AND RESTATED PROMISSORY NOTE, DATED AUGUST 7, 2025, BY AND BETWEEN VERU,","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025074952/ea025275901ex10-2_oncone.htm","primary":false,"translateUrl":"","linkName":"ea025275901ex10-2_oncone.htm","type":"EX-10.2","id":"NTFILE3hQvfRy5wnP97HgG","market":"us","size":25808}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-13 04:06","pubTimestamp":1755029168,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第2.03项：直接财务义务或注册人资产负债表外安排下的义务的产生；第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19883908","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025064469-ONCO","pdf_url":"","pub_time":1752638400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025064469/0001213900-25-064469-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AGREEMENT AND PLAN OF MERGER, DATED JULY 16, 2025, BY AND AMONG PARENT, THE COMP","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025064469/ea024881501ex2-1_oncone.htm","primary":true,"translateUrl":"","linkName":"ea024881501ex2-1_oncone.htm","type":"EX-2.1","id":"NTFILE2xbnVCAdM3sCpsQe","market":"us","size":735580},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025064469/ea0248815-8k_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea0248815-8k_onconetix.htm","type":"8-K","id":"NTFILE2KQdYbUv9T3MQgUw","market":"us","size":86912},{"description":"FORM OF LOCK-UP AGREEMENT, DATED JULY 16, 2025, BY AND AMONG PARENT, PARENT REPR","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025064469/ea024881501ex10-1_oncone.htm","primary":false,"translateUrl":"","linkName":"ea024881501ex10-1_oncone.htm","type":"EX-10.1","id":"NTFILEDhwHnSMxskXkoF68","market":"us","size":46308},{"description":"FORM OF COMPANY SUPPORT AGREEMENT, DATED JULY 16, 2025, BY AND AMONG PARENT, THE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025064469/ea024881501ex10-2_oncone.htm","primary":false,"translateUrl":"","linkName":"ea024881501ex10-2_oncone.htm","type":"EX-10.2","id":"NTFILEFgxYuAxbWZUam95a","market":"us","size":38173},{"description":"FORM OF CONVERSION PRICE REDUCTION CONSENT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025064469/ea024881501ex10-3_oncone.htm","primary":false,"translateUrl":"","linkName":"ea024881501ex10-3_oncone.htm","type":"EX-10.3","id":"NTFILEFyeQnDWf6hVBudbi","market":"us","size":20749},{"description":"PRESS RELEASE, DATED JULY 16, 2025","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025064469/ea024881501ex99-1_oncone.htm","primary":false,"translateUrl":"","linkName":"ea024881501ex99-1_oncone.htm","type":"EX-99.1","id":"NTFILE2vrEDqK9vam5qADu","market":"us","size":21180},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025064469/ex10-3_001.jpg","primary":false,"translateUrl":"","linkName":"ex10-3_001.jpg","type":"GRAPHIC","id":"NTFILEEogXdBHWHBzDk6QB","market":"us","size":4812},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025064469/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEFpL32BCVCTBAVVwN","market":"us","size":11031}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-16 12:00","pubTimestamp":1752638400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19776026","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025054501-ONCO","pdf_url":"","pub_time":1750046400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ONCO","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025054501/0001213900-25-054501-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, DATED JUNE 16, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025054501/ea024581801ex99-1_onconetix.htm","primary":true,"translateUrl":"","linkName":"ea024581801ex99-1_onconetix.htm","type":"EX-99.1","id":"NTFILEAoQjHLtHUnvz4RJu","market":"us","size":8025},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025054501/ea0245818-8k_onconetix.htm","primary":false,"translateUrl":"","linkName":"ea0245818-8k_onconetix.htm","type":"8-K","id":"NTFILEH1idu6JHJmxTzr8E","market":"us","size":24033}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-16 12:00","pubTimestamp":1750046400,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.onconetix.com","stockEarnings":[{"period":"1week","weight":0.1824},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.4898},{"period":"6month","weight":-0.5152},{"period":"1year","weight":-0.9612},{"period":"ytd","weight":0.1218}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0044},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.068},{"period":"1year","weight":0.1339},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Onconetix, Inc.于2018年10月26日在特拉华州注册成立。该公司是一家商业阶段的生物技术公司，专注于为临床医生和患者提供肿瘤学专有疗法、诊断和服务的研究、开发和商业化。该公司目前拥有FDA批准的用于治疗良性前列腺增生（BPH）（一种前列腺疾病）的口服治疗药物EntadFi，以及用于在前列腺癌肿瘤学中筛查和诊断前列腺特异性抗原（PSA）评估不确定的男性的先进专有诊断系统Proclarix。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.017234},{"month":2,"riseRate":0,"avgChangeRate":-0.233116},{"month":3,"riseRate":0.25,"avgChangeRate":-0.182623},{"month":4,"riseRate":0,"avgChangeRate":-0.309723},{"month":5,"riseRate":0.75,"avgChangeRate":0.202403},{"month":6,"riseRate":0.25,"avgChangeRate":-0.145881},{"month":7,"riseRate":0.25,"avgChangeRate":0.061534},{"month":8,"riseRate":0,"avgChangeRate":-0.163365},{"month":9,"riseRate":0.25,"avgChangeRate":-0.19953},{"month":10,"riseRate":0.25,"avgChangeRate":-0.216685},{"month":11,"riseRate":0.25,"avgChangeRate":-0.325466},{"month":12,"riseRate":0,"avgChangeRate":-0.20858}],"exchange":"NASDAQ","name":"Onconetix Inc.","nameEN":"Onconetix Inc."},"aProfile":null}}}